These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3738429)

  • 41. Clonal evolution at leukemic relapse of multiple myeloma (secondary plasma cell leukemia) responding to re-treatment with bortezomib-based therapy. A case record.
    Bernardeschi P; Pirrotta MT; Montenora I; Giustarini G; Ferreri MI; Simi P; Fiorentini G
    Leuk Res; 2010 Apr; 34(4):e104-5. PubMed ID: 19889456
    [No Abstract]   [Full Text] [Related]  

  • 42. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.
    Millá F; Oriol A; Aguilar J; Aventín A; Ayats R; Alonso E; Domingo A; Feliu E; Florensa L; López A; Pérez-Vila E; Rozman M; Sánchez C; Vallespí T; Woessner S
    Am J Clin Pathol; 2001 Jan; 115(1):127-35. PubMed ID: 11190798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
    Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
    Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma cell dyscrasias.
    Buss DH; Prichard RW; Cooper MR
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):603-15. PubMed ID: 3065321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
    Treon SP; Anderson KC
    Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The generation and regulation of functional diversity of malignant plasma cells.
    Nadav L; Katz BZ; Baron S; Cohen N; Naparstek E; Geiger B
    Cancer Res; 2006 Sep; 66(17):8608-16. PubMed ID: 16951174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
    Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Horak P; Minarik J
    Haematologica; 2005 Dec; 90(12):1713-4. PubMed ID: 16330455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.
    McElwain TJ; Powles RL
    Lancet; 1983 Oct; 2(8354):822-4. PubMed ID: 6137651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple myeloma.
    Kumar SK; Rajkumar V; Kyle RA; van Duin M; Sonneveld P; Mateos MV; Gay F; Anderson KC
    Nat Rev Dis Primers; 2017 Jul; 3():17046. PubMed ID: 28726797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
    Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
    Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Multiple myeloma with cutaneous involvement in a patient with long-standing MGUS].
    Giraldo MP; Delgado MP; Rubio Félix D
    Sangre (Barc); 1993 Apr; 38(2):156-7. PubMed ID: 8516731
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma cell leukaemia; report of a case.
    SMITH F
    N Z Med J; 1956 Oct; 55(309):388-90. PubMed ID: 13388083
    [No Abstract]   [Full Text] [Related]  

  • 54. [Implication of bone marrow microenvironment in pathogenesis of multiple myeloma].
    Fišerová B; Kubiczková L; Sevčíková S; Hájek R
    Klin Onkol; 2012; 25(4):234-40. PubMed ID: 22920162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
    Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of sizes and shapes of tumor cells in plasma cell leukemia and plasma cell myeloma.
    Isobe T; Ikeda Y; Ohta H
    Blood; 1979 May; 53(5):1028-30. PubMed ID: 435639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical Localization of Malignant Plasma Cells in Non-Viable Cell Area on Flow Cytometry Light-Scatter Dot Plot.
    Juranovic T; Harvey G; Johnson J; Zhang D; Plata MJ; Estalilla OC; Jelic TM
    Am J Case Rep; 2018 Aug; 19():1019-1024. PubMed ID: 30146632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights in the clinical biology of multiple myeloma.
    Bataille R
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):23-8. PubMed ID: 9122743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.